![](/img/cover-not-exists.png)
Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations
Cárdenas-Soto, Karla, Torres-Octavo, Benjamín, Mendoza-Tejeda, Claudia, Fueyo-Rodríguez, Omar, Domínguez-Rico, Carolina, Gonzalez-Duarte, AlejandraVolume:
26
Language:
english
Journal:
Amyloid
DOI:
10.1080/13506129.2019.1582520
Date:
March, 2019
File:
PDF, 599 KB
english, 2019